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Yogi Berra, the former New York Yankees 
baseball manager, known for his interesting 
phraseology, famously once said, “It’s tough 
to make predictions, especially about the 
future.” While this has become somewhat 
of a tired cliché, there is an inherent validity 
to the argument that makes us somewhat 
cautious  and  humble  in  any  discussion 
regarding the future of Neurology. At the 
risk of fumbling our way toward the truth, 
we remind ourselves that in order to find the 
truth, we need to ask the right questions.
Other colleagues have written eloquently 
about  the  changing  role  of  neurologists 
(Engstrom and Hauser, 1994; Bradley, 2000; 
Freeman and Vatz, 2010), and the fundamen-
tal changes facing Child Neurology (Ridel 
and  Gilbert,  2010). A  continuous  stream 
of advances in basic neuroscience research, 
gene identification, neurogenomics, cutting-
edge  genetic  techniques,  neurodiagnostic 
tools  including  advanced  neuroimaging 
technologies (Masdeu and Bakshi, 2005), 
and longitudinal biomarkers, coupled with 
new treatment modalities and paradigms 
for neurologic disease, suggests increased 
demands on available practitioners. In view 
of the growing aging population, associated 
with declines in infant mortality and treat-
ment of infectious disease, more people will 
suffer from age related neurologic disorders 
such as stroke, dementia, Parkinson’s dis-
ease, epilepsy, and autoimmune disorders 
(Engstrom and Hauser, 1994; Bradley, 2000; 
Freeman and Vatz, 2010; Weiner, 2007).
In the past, a neurologist was recognized 
particularly for skilled diagnoses using clues 
derived from a thorough and elaborate his-
tory and physical examination, but treat-
ment  options  were  limited.  Colloquially, 
the neurologist would “diagnose and adios.” 
With the advent of advanced neuroimaging 
and laboratory techniques, there has been 
much lament about the disappearance of the 
neurologists’ much vaunted skill in clinical 
diagnosis. And yet, the various tests, coupled 
with advanced treatment techniques, have 
certainly led to an explosion of opportunity, 
with both increased demand for neurolo-
gists and an increased number of people 
interested in the field.
In the near future, the role of diagnos-
tic testing in clinical neurology (as in all of 
medicine) will only further accelerate. There 
will be some value to the diagnostic prowess 
of neurologists in determining the appropri-
ateness and meaning of complex and poten-
tially unnecessary tests and procedures. As 
noted by Gooch and Amato (2010), in a 
discussion of the utility of anti-ganglioside 
antibodies  in  the  diagnosis  of  multifocal 
motor neuropathy: “In this era of limited 
resources, the judicious exercise of sound 
clinical judgment in crafting a logical and 
efficient  diagnostic  evaluation  has  never 
been  more  important.  Careful  selection 
of the best path to the final diagnosis will 
not only most benefit our patients but will 
also as health reform continues to advance, 
insure that our precious (and finite) medical 
resources are not necessarily wasted” (Gooch 
and Amato, 2010). Still, academicians simply 
become Luddites if they lament how testing 
has superseded the neurologic history and 
physical examination which were never as 
accurate as we cared to admit. We respect-
fully suggest that the future of neurology will 
be critically dependent on harmonizing the 
tensions between clinical skills and an over-
reliance on testing paradigms.
The  future  of  Neurology  will  also  be 
reflected  in  the  greater  opportunities  to 
develop therapeutic interventions, delay, or 
ideally prevent progressive neurodegenera-
tive diseases, and the roles to be played by the 
new breed of neurologists in providing these 
interventions. There will likely be explosive 
growth in potential medical therapies includ-
ing novel drugs, human pluripotent stem 
cell technology and gene therapies, and new 
immunosuppressant modalities in the near 
future (Mallarkey, 2008). There will also be 
an increased role for neurologists in inter-
ventional fields such as stroke, pain, neuros-
timulation, and even neuroregeneration.
There will also be a continued separa-
tion between the practice of intensive and 
hospital-based neurology and office-based 
general and specialty neurology. The par-
allels  with  Cardiology/Internal  Medicine 
combined with the growth of procedural 
non-surgical  focused  specialists  in  these 
fields are both obvious and inevitable given 
the profound shift toward a treatment ori-
ented focus for neurology in the near future. 
The challenge for neurology will be whether 
we  can  satisfy  the  need  for  neurologic 
expertise in providing these treatments or 
whether others will pick up the slack for this 
pent-up demand for aggressive treatment of 
  neurologic disease.
The field of neurology remains one of 
the most dynamic areas of medicine, with 
advances  on  many  fronts.  Frontiers  in 
Neurology offers an unprecedented oppor-
tunity for a more accessible, more manage-
able, and more useful dynamic interactive 
seminal exchange between the world com-
munity of neurologists and neuroscientists 
striving toward a common goal of excel-
lence. Only by sharing your expertise and 
knowledge with the neurological commu-
nity, can we achieve our ultimate goal of 
improving the quality of life and outcomes 
for patients with neurological disorders.
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